Loss of Dicer has been associated with decreased chemosensitivity and cell proliferation in ovarian cancers (49) but, conversely, also with increased cisplatin sensitivity and cell proliferation in MCF-7 breast cancer cells (50). Here, DICER1 is linked to breast carcinoma.